Myriad Genetics
MYGN
#5904
Rank
$0.74 B
Marketcap
$8.13
Share price
-3.33%
Change (1 day)
-59.87%
Change (1 year)

Revenue for Myriad Genetics (MYGN)

Revenue in 2024 (TTM): $0.83 Billion USD

According to Myriad Genetics's latest financial reports the company's current revenue (TTM ) is $0.83 Billion USD. an increase over the revenue in the year 2023 that were of $0.75 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Myriad Genetics from 1996 to 2024

20002005201020152020$0.2B$0.4B$0.6B$0.8B$1Bcompaniesmarketcap.com

Annual revenue

Year Revenue Change
2024 $0.83 B11.21%
2023 $0.75 B11.03%
2022 $0.67 B-1.77%
2021 $0.69 B
2019 $0.81 B2.04%
2018 $0.79 B4.32%
2017 $0.76 B1.76%
2016 $0.75 B0.56%
2015 $0.74 B3.01%
2014 $0.72 B-1.66%
2013 $0.73 B35.17%
2012 $0.54 B23.08%
2011 $0.44 B17.5%
2010 $0.37 B9.15%
2009 $0.34 B-10.56%
2008 $0.38 B101.73%
2007 $0.19 B44.48%
2006 $0.13 B34.53%
2005 $98.5 M51.13%
2004 $65.17 M9.34%
2003 $59.61 M-0.15%
2002 $59.7 M21.7%
2001 $49.05 M17.79%
2000 $41.64 M42.81%
1999 $29.16 M24.09%
1998 $23.5 M10.85%
1997 $21.2 M138.2%
1996 $8.9 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
$2.56 B 206.41%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.75 B 229.38%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.44 Million-100.41%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.85 B 240.73%๐Ÿ‡บ๐Ÿ‡ธ USA
$41.95 B 4,908.36%๐Ÿ‡บ๐Ÿ‡ธ USA